Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.930
+0.380 (10.70%)
At close: Feb 6, 2026, 4:00 PM EST
4.000
+0.070 (1.78%)
After-hours: Feb 6, 2026, 7:57 PM EST
Sana Biotechnology Employees
Sana Biotechnology had 194 employees as of December 31, 2024. The number of employees decreased by 134 or -40.85% compared to the previous year.
Employees
194
Change (1Y)
-134
Growth (1Y)
-40.85%
Revenue / Employee
n/a
Profits / Employee
-$1,208,299
Market Cap
1.05B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 194 | -134 | -40.85% | 194 | 0 |
| Dec 31, 2023 | 328 | -93 | -22.09% | 328 | 0 |
| Dec 31, 2022 | 421 | 35 | 9.07% | 418 | 3 |
| Dec 31, 2021 | 386 | 121 | 45.66% | 383 | 3 |
| Dec 31, 2020 | 265 | - | - | 263 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 838 |
| Phathom Pharmaceuticals | 427 |
| Vir Biotechnology | 408 |
| UroGen Pharma | 287 |
| Geron | 229 |
| ARS Pharmaceuticals | 167 |
| CytomX Therapeutics | 121 |
| ORIC Pharmaceuticals | 106 |
SANA News
- 19 days ago - Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips - Seeking Alpha
- 24 days ago - Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform - GlobeNewsWire
- 2 months ago - Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Sana Biotechnology to Present at December 2025 Investor Conferences - GlobeNewsWire
- 4 months ago - Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D - Seeking Alpha